Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02315469 · ClinicalTrials.gov registry record
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
A clinical trial, sponsored by NRG Oncology.
- Completed
- Registry status
- 190
- Enrollment target
NCT02315469: Completed study, sponsored by NRG Oncology.
NCT02315469 is a clinical trial that has completed, run by NRG Oncology. The registered enrollment target is 190 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02315469 has completed, sponsored by NRG Oncology.
- COMPLETED
- Registry status
- 190 participants
- Enrollment target
Study Summary
This research trial studies comprehensive patient questionnaires in predicting complications in older patients with gynecologic cancer undergoing surgery. Comprehensive patient questionnaires completed before surgery may help identify complications, such as the need for assistance in taking medications, decreased mobility, decreased social activity, and falls, and may improve outcomes for older patients with gynecologic cancer.
Interventions
- OTHER Questionnaire Administration
- OTHER Comprehensive Geriatric Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2015-02-10 |
| Est. Completion | 2019-02-09 |
What the finished NCT02315469 record still lists
NCT02315469 is an observational study that tracks outcomes without assigning an intervention. The registered 190 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT02315469 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02315469 about?
NCT02315469 is a clinical study titled "Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery". This research trial studies comprehensive patient questionnaires in predicting complications in older patients with gynecologic cancer undergoing surgery. Comprehensive patient questionnaires completed before surgery may help identify complications, such as the need for assistance in taking medicati...
What is the current status of trial NCT02315469?
This trial is currently completed. The enrollment target is 190 participants. The study started on 2015-02-10. Estimated completion is 2019-02-09.
What interventions are being tested in trial NCT02315469?
The interventions under investigation include: Questionnaire Administration (OTHER), Comprehensive Geriatric Assessment (OTHER).
Who is sponsoring clinical trial NCT02315469?
This trial is sponsored by NRG Oncology, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03257033 · 190 participants · Phase 3
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
- NCT03642028 · 190 participants · Phase 4
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
- NCT04015609 · 190 participants · NA
Psychotherapy Intervention for Latinos With Advanced Cancer
- NCT04284397 · 190 participants · Early Phase 1
Identification of Critical Thermal Environments for Aged Adults
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI